Ameriprise Financial Inc Kala Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$4.29 - $9.94 $221,449 - $513,102	-51,620 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$9.54 - $13.87 $128,026 - $186,135	-13,420 Reduced 20.63%	51,620 $509,000
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.49 $77,672 - $102,141	5,840 Added 9.86%	65,040 $893,000
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $172,866 - $267,618	14,100 Added 31.26%	59,200 $937,000
Q4 2017 Feb 12, 2018	BUY	$13.68 - $23.17 $280,440 - $474,985	20,500 Added 83.33%	45,100 $834,000
Q3 2017 Nov 07, 2017	BUY	$19.86 - $26.53 $488,556 - $652,638	24,600	24,600 $562,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $12.3M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.